Autoimmune lesions of thyroid as complications of interferon treatment of chronic viral hepatitis
Ettinger, O.A.; Nikitin, I.G.; Storozhakov, G.I.
Terapevticheskii Arkhiv 71(12): 69-72
1999
ISSN/ISBN: 0040-3660 PMID: 10647210 Document Number: 510836
Document emailed within 1 workday
Related Documents
Wright, H.I. 1990: Interferon treatment of chronic viral hepatitis G.E.N 44(1): 71-77Pirovino, M. 1992: Interferon treatment of chronic viral hepatitis Therapeutische Umschau. Revue Therapeutique 49(5): 302-309
Bojić, I. 1997: Autoimmune hepatitis and autoimmune manifestations in patients with chronic viral hepatitis Medicinski Pregled 50(9-10): 363-368
Tóthová, E.; Stecová, N.; Kafková, A.; Fricová, M.; Svorcová, E. 2002: Occurrence of autoimmune complications in patients with chronic myelocytic leukemia during treatment with interferon alfa Vnitrni Lekarstvi 48(5): 380-383
Beker, S.; Pujol, F.H.; Beker, B. 1995: Is the treatment of chronic viral hepatitis C with interferon-alpha effective? G.E.N 49(2): 165-169
Primo, J.; Hinojosu, J.; Molés, J.R.; Fernández, J.; Martinez, C.; Miralles, A.; Otte, A. 1993: Development of thyroid dysfunction after alpha-interferon treatment of chronic hepatitis C American Journal of Gastroenterology 88(11): 1976-1977
Kokoreva, L.N.; Zmyzgova, A.V.; Shalygina, N.B. 1996: The interferon therapy of patients with chronic viral hepatitis: the factors affecting the treatment results Terapevticheskii Arkhiv 68(2): 10-14
Xin-Hua, W.; Chang-Qing, L.; Xing-Bo, G.; Lin-Chun, F. 2001: A comparative study of Phyllanthus amarus compound and interferon in the treatment of chronic viral hepatitis B Southeast Asian Journal of Tropical Medicine and Public Health 32(1): 140-142
Nakamura, H.; Ogawa, H.; Kuroda, T.; Yamamoto, M.; Enomoto, H.; Kishima, Y.; Yoshida, K.; Ito, H.; Matsuda, M.; Noguchi, S. 2002: Interferon treatment for patients with chronic hepatitis C infected with high viral load of genotype 2 virus Hepato-Gastroenterology 49(47): 1373-1376
Zielińska, W.; Korczak-Rogoń, A.; Paszkiewicz, J.; Kowalik, M.; Cummins, J.M.; Georgiades, J.A. 1996: Comparison of the long-term effects of treatment with oral and parenteral interferon alpha in chronic viral hepatitis patients Archivum Immunologiae et Therapiae Experimentalis 44(5-6): 359-366
Mozer-Lisewska, I.; Dworacki, G.; Kaczmarek, E.; Słuzewski, W.; Kowala-Piaskowska, A.; Figlerowicz, M.; Kaczmarek, M.; Zeromski, J. 2005: Alterations within white blood cell subsets in children with chronic viral hepatitis C before treatment with pegylated interferon and ribavirin Przeglad Epidemiologiczny 59(2): 483-489
Hrycewycz, N.; Sandres, K.; Barange, K.; Pascal, J.P.; Izopet, J.; Payen, J.L. 2001: Eradication of hepatitis C virus after 3 months of interferon and ribavirin treatment in an a interferon non-responder patient with chronic hepatitis C Gastroenterologie Clinique et Biologique 25(11): 1041-1042
Mackay, I.R.; Frazer, I.H.; Toh, B.H.; Pedersen, J.S.; Alter, H.J. 1985: Absence of autoimmune serological reactions in chronic non A, non B viral hepatitis Clinical and Experimental Immunology 61(1): 39-43
Alscher, D.M.; Bode, J.C. 1992: Therapy of acute and chronic viral hepatitis C (non-A, non-B) with interferon-alpha Medizinische Klinik 87(10): 532-539
Soriano, V.; García-Samaniego, J. 1994: Therapy with interferon in HIV-infected patients with chronic viral hepatitis Revista Clinica Espanola 194(10): 887-889
Gschwantler, M.; Schrutka-Kölbl, C.; Weiss, W. 1995: Acute exacerbation of antiliver cytosol antibody-positive autoimmune chronic hepatitis by alpha-interferon American Journal of Gastroenterology 90(12): 2239-2240
Rocco, A.; Gargano, S.; Provenzano, A.; Nardone, M.; De Sanctis, G.M.; Altavilla, N.; Chircu, L.V.; Grimaldi, F. 2001: Incidence of autoimmune thyroiditis in interferon-alpha treated and untreated patients with chronic hepatitis C virus infection Neuro Endocrinology Letters 22(1): 39-44
Juszczyk, J.; Baka-Cwierz, B.; Beniowski, M.; Berak, H.; Bolewska, B.; Boroń-Kaczmarska, A.; Cianciara, J.; Cieśla, A.; Dziambor, A.; Gasiorowski, J.; Gietka, A.; Gliwińska, E.; Gładysz, A.; Gonciarz, Z.; Halota, W.; Horban, A.; Inglot, Młgorzata.; Janas-Skulina, U.; Janczewska-Kazek, E.; Jaskowska, J.; Jurczyk, K.; Knysz, B.; Kryczka, Wław.; Kuydowicz, J.; Lakomy, E.A.; Logiewa-Bazger, B.; Lyczak, A.; Mach, T.; Mazur, Włodzimierz.; Michalska, Z.; Modrzewska, R.; Nazzal, K.; Pabjan, Pł.; Piekarska, A.; Piszko, Pł.; Sikorska, K.; Szamotulska, K.; Sliwińska, M 2005: Pegylated interferon-alfa 2a with ribavirin in chronic viral hepatitis C (final report) Przeglad Epidemiologiczny 59(3): 651-660
Mohran, Z.Y.; Abdel Kader, N.A.; Abdel Moez, A.T.; Abbas, A.A. 2010: Subclinical autoimmune thyroid disorders in Egyptian patients with untreated chronic hepatitis C virus infection Journal of the Egyptian Society of Parasitology 40(1): 45-56
Musch, E.; Högemann, B.; Gerritzen, A.; Fischer, H.P.; Wiese, M.; Kruis, W.; Malek, M.; Gugler, R.; Schmidt, G.; Huchzermeyer, H.; Gerlach, U.; Dengler, H.J.; Sauerbruch, T. 1998: Phase Ii clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B Hepato-Gastroenterology 45(24): 2282-2294